Point of Care Molecular Diagnostics Market |Expected to reach USD 1440.2 Million by 2023|at a CAGR of 14.7%

Point of Care Molecular Diagnostics Market  is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%. Growth in the point-of-care (POC) molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.

Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=143524127

Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) – Global Forecast to 2023, published by MarketsandMarkets™

Scope of the Report

The research report categorizes the global POC molecular diagnostics market into the following segments and subsegments:

  • POC molecular  Diagnostics Market, by Product & Service
    • Assays & Kits
    • Instruments/Analyzers
    • Services & Software
  • POC Molecular Diagnostics Market, by Application
    • Respiratory diseases
    • STDs
    • HAIs
    • Oncology
    • Hepatitis
    • Other Applications
  • POC Molecular Diagnostics Market, by Technology
    • RT-PCR
    • INAAT
    • Others Technologies
  • POC Molecular  Diagnostics Market, by End User
    • Physician Offices
    • Hospital Emergency Departments & Intensive Care Units
    • Research Institutes
    • Other End User
  • POC Molecular  Diagnostics Market, by Region
    • North America
      • US
      • Canada
    • Europe
    • Asia Pacific
    • Rest of the World (RoW)

To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

You May Also Like